Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)Enrique Grande, Rocio García‐Carbonero, Daniel Castellano et al.|Annals of Oncology|2015Cited by 157
Multicenter study correlating molecular characteristics and clinical outcomes of cancer cases with patient-derived organoidsPaloma Navarro, Jesús García-Donás|Journal of Experimental & Clinical Cancer Research|2025Cited by 6